Skip to main content
. 2020 Dec 8;4(23):6051–6063. doi: 10.1182/bloodadvances.2020003471

Table 3.

Criteria for TMA in patients with MIS-C, minimal COVID-19, and severe COVID-19

ID Age, y Other conditions Elevated LDH Schistocytes Low platelets Anemia HTN Protein in urine Elevated sC5b9 Met criteria for TMA? No. of criterion
Minimal COVID-19
 13 4 Sickle cell disease Yes 5
 38 17 Obesity, asthma Yes 5
Summary: fraction (%) 2/2 (100) 1/2 (50) 2/2 (100) 1/2 (50) 2/2 (100) 1/2 (50) 1/2 (50) 2/2 (100)
Severe COVID-19
 10 10 Panhypopituitarism Yes 6
 33 15 Obesity, PCOS Yes 5
 37 15 Obesity Yes 6
 4 18 Obesity, hypertension, diabetes mellitus Yes 7
 Summary: fraction (%) 4/4 (100) 4/4 (100) 2/4 (67) 4/4 (100) 3/4 (75) 3/4 (75) 4/4 (100) 4/4 (100)
MIS-C
 19 5 Previously healthy Yes 6
 22 6 Previously healthy Yes 6
 18 6 Previously healthy Yes 7
 24 7 Previously healthy Yes 6
 29 8 Asthma Yes 5
 44 8 Previously healthy Yes 5
 55 8 Precocious puberty Yes 6
 28 9 Previously healthy Yes 5
 50 9 Previously healthy Yes 7
 48 11 Previously healthy Yes 5
 26 13 Previously healthy Yes 5
 27 14 Previously healthy No 4
 51 17 Asthma No 4
 Summary: fraction (%) 8/13(61) 12/13 (92) 8/13(61) 12/13 (92) 10/13 (76) 9/13 (69) 12/13 (92) 11/13 (85)

Criteria for TMA as defined by Gloude et al.27 Meeting at least 5 of the 7 criteria are required to meet definition. Protein in urine defined as random urine protein measurement ≥30 mg/dL or urine protein/creatinine ratio ≥2 mg/mg. Hypertension defined as >99th percentile for age, height, and sex. Check marks indicate that the criterion was met; blank spaces indicate that the criterion was not met.

B-ALL, B-cell acute lymphoblastic leukemia; HTN, hypertension; PCOS, polycystic ovarian syndrome.